Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases

MJ Betts, E Kirilina, MCG Otaduy, D Ivanov… - Brain, 2019 - academic.oup.com
Pathological alterations to the locus coeruleus, the major source of noradrenaline in the
brain, are histologically evident in early stages of neurodegenerative diseases. Novel MRI …

The locus coeruleus: essential for maintaining cognitive function and the aging brain

M Mather, CW Harley - Trends in cognitive sciences, 2016 - cell.com
Research on cognitive aging has focused on how decline in various cortical and
hippocampal regions influence cognition. However, brainstem regions play essential …

[HTML][HTML] The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review

E Aaldijk, Y Vermeiren - Ageing Research Reviews, 2022 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, accounting for more than
50 million patients worldwide. Current evidence suggests the exact mechanism behind this …

Long road to ruin: noradrenergic dysfunction in neurodegenerative disease

D Weinshenker - Trends in neurosciences, 2018 - cell.com
It has been known for decades that degeneration of the locus coeruleus (LC), the major
noradrenergic nucleus in the brain, occurs in both Alzheimer's disease (AD) and Parkinson's …

[HTML][HTML] Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease

SC Kelly, B He, SE Perez, SD Ginsberg… - Acta neuropathologica …, 2017 - Springer
A major feature of Alzheimer's disease (AD) is the loss of noradrenergic locus coeruleus
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …

Monoaminergic neuropathology in Alzheimer's disease

G Šimić, MB Leko, S Wray, CR Harrington… - Progress in …, 2017 - Elsevier
None of the proposed mechanisms of Alzheimer's disease (AD) fully explains the distribution
patterns of the neuropathological changes at the cellular and regional levels, and their …

Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care

L Trillo, D Das, W Hsieh, B Medina… - Neuroscience & …, 2013 - Elsevier
Extensive neuropathological studies have established a compelling link between
abnormalities in structure and function of subcortical monoaminergic (MA-ergic) systems …

Oxidative stress: free radical production in neural degeneration

ME Götz, G Künig, P Riederer, MBH Youdim - Pharmacology & therapeutics, 1994 - Elsevier
It is not yet established whether oxidative stress is a major cause of cell death or simply a
consequence of an unknown pathogenetic factor. Concerning chronic diseases, as …

The neuropathology of aminergic nuclei in Alzheimer's disease

RM Zweig, CA Ross, JC Hedreen… - Annals of Neurology …, 1988 - Wiley Online Library
Neuronal loss and the presence of neurofibrillary tangles (NFTs) within aminergic nuclei
were examined in a series of patients with Alzheimer's disease (AD). Neuromelanin …

A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

AI Levey, D Qiu, L Zhao, WT Hu, DM Duong… - Brain, 2022 - academic.oup.com
The locus coeruleus is the initial site of Alzheimer's disease neuropathology, with
hyperphosphorylated Tau appearing in early adulthood followed by neurodegeneration in …